4.2 Article

Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

期刊

NEUROMUSCULAR DISORDERS
卷 19, 期 2, 页码 151-154

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2008.11.002

关键词

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE); Thymidine phosphorylase; TYMP; Mitochondrial DNA

资金

  1. Ambrose and Ann Appelbe Trust
  2. MRC [G0601943] Funding Source: UKRI
  3. Medical Research Council [G0601943, G0601943B] Funding Source: researchfish

向作者/读者索取更多资源

Mitochondrial neurogastrointestinal encephalomyopathy is an autosomal recessive disorder caused by loss-of-function mutations in the thymidine phosphorylase gene (TYMP). We report here a patient compound heterozygous for two TYMP mutations: a novel g.4009G>A transition affecting the consensus splice donor site of intron 9, and a previously reported g.675G>C splice site mutation. The novel mutation causes exon 9 skipping but leaves the reading frame intact: however, TYMP protein was not detected by immunoblot analysis, suggesting that neither mutant allele is expressed as protein. The patient's fibroblasts showed gradual loss of the mitochondrial DNA-encoded subunit 1 of cytochrome-c oxidase, suggesting a progressive mitochondrial DNA defect in culture. (C) 2008 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Medicine, General & Internal

Surveys are not simple: beware of the pitfalls

Philip D. Welsby, Mark Weatherall

Summary: This paper outlines the various problems that may be encountered when producing surveys.

POSTGRADUATE MEDICAL JOURNAL (2023)

Article Respiratory System

Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial

Nethmi Kearns, Mathew Williams, Pepa Bruce, Melissa Black, Cilein Kearns, Jenny Sparks, Irene Braithwaite, Mark Weatherall, Richard Beasley

Summary: This study compared the bronchodilator response of salbutamol and budesonide/formoterol in adults with stable asthma. The results showed that after 2 minutes of treatment administration, both budesonide/formoterol and salbutamol had minimal changes in FEV1, but salbutamol had a stronger response in FEV1 over 30 minutes.

THORAX (2023)

Article Gastroenterology & Hepatology

TiO2 nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locus

Marlene Schwarzfischer, Anna Niechcial, Kristina Handler, Yasser Morsy, Marcin Wawrzyniak, Andrea S. Laimbacher, Kirstin Atrott, Roberto Manzini, Katharina Baebler, Larissa Hering, Egle Katkeviciute, Janine Hafliger, Silvia Lang, Maja E. Keller, Jerome Woodtli, Lisa Eisenbeiss, Thomas Kraemer, Elisabeth M. Schraner, Mahesa Wiesendanger, Sebastian Zeissig, Gerhard Rogler, Andreas E. Moor, Michael Scharl, Marianne R. Spalinger

Summary: This study investigates the interaction between the PTPN22 gene variation and food-grade titanium dioxide nanoparticles in the pathogenesis of inflammatory bowel disease (IBD). The results show that the ingestion of titanium dioxide nanoparticles makes mice carrying the PTPN22 variation susceptible to IBD and triggers severe intestinal inflammation. This demonstrates that environmental factors can interact with genetic risk variants and reverse a protective mechanism into a disease-promoting effect.
Article Biochemistry & Molecular Biology

The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines

Laura J. Smith, Magdalena M. Bolsinger, Kai-Yin Chau, Matthew E. Gegg, Anthony H. Schapira

Summary: Sequence variants or mutations in the GBA gene are the most important risk factor for Parkinson's disease. This study characterizes the effects of the E326K variant in human cells and finds that it behaves differently compared to other common GBA mutations. However, lipid imbalance and alpha-synuclein pathology are still observed.

HUMAN MOLECULAR GENETICS (2023)

Article Gastroenterology & Hepatology

European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

Joana Torres, Maria Chaparro, Mette Julsgaard, Konstantinos Katsanos, Zuzana Zelinkova, Manasi Agrawal, Sandro Ardizzone, Marjo Campmans-Kuijpers, Gabriele Dragoni, Marc Ferrante, Gionata Fiorino, Emma Flanagan, Catarina Frias Gomes, Ailsa Hart, Charlotte Rose Hedin, Pascal Juillerat, Annemarie Mulders, Par Myrelid, Aoibhlinn O'Toole, Pauline Riviere, Michael Scharl, Christian Philipp Selinger, Elena Sonnenberg, Murat Toruner, Jantien Wieringa, C. Janneke Van der Woude

JOURNAL OF CROHNS & COLITIS (2023)

Review Clinical Neurology

Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts

Patrick W. Cullinane, Eduardo de Pablo Fernandez, Annekatrin Konig, Tiago Fleming Outeiro, Zane Jaunmuktane, Thomas T. Warner

Summary: Highly reproducible epidemiological evidence suggests that type 2 diabetes (T2D) increases the risk and progression of Parkinson's disease (PD) and repurposing certain antidiabetic medications for PD treatment shows promise. The high prevalence of T2D highlights the need for personalized antidiabetic treatment in PD patients. However, understanding the mechanistic relation and molecular pathways affected by T2D in the brain is essential. The review focuses on the evidence of T2D-associated dysregulation in peripheral and brain pathways, its impact on neurodegeneration in PD, and the challenges in unraveling the complex relationship between T2D, insulin resistance, and PD.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Pathological Validation of the MDS Criteria for the Diagnosis of Multiple System Atrophy

Sasivimol Virameteekul, Tamas Revesz, Zane Jaunmuktane, Thomas T. Warner, Eduardo De Pablo-Fernandez

Summary: The recent MDS-MSA diagnostic criteria have been validated against neuropathological diagnosis and shown excellent diagnostic performance. They outperformed previous criteria and clinical diagnosis, demonstrating their usefulness in clinical practice and research.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?

Sasivimol Virameteekul, Tamas Revesz, Zane Jaunmuktane, Thomas T. Warner, Eduardo De Pablo-Fernandez

Summary: This study retrospectively analyzed the clinical diagnostic accuracy data of patients with Parkinson's disease confirmed by neuropathology between 2009 and 2019. The results showed a significant improvement in clinical diagnostic accuracy of Parkinson's disease over the past decade, especially in early stages. The diagnosis by movement disorder experts remains the "gold standard" for Parkinson's disease during life.

MOVEMENT DISORDERS (2023)

Letter Clinical Neurology

Alzheimer's disease pathology concomitant with memory impairment in late-onset multiple system atrophy

Yasuo Miki, Conceicao Bettencourt, Zane Jaunmuktane, Janice L. Holton, Thomas T. Warner, Koichi Wakabayashi

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Clinical Neurology

Globular glial tauopathy type II

Patrick W. Cullinane, Katie Sidle, Kailash P. Bhatia, Tamas Revesz, Thomas T. Warner

Summary: Globular glial tauopathies (GGTs) are a rare group of neurodegenerative diseases. Recent research supports the idea that GGT should be considered as a separate entity within neuropathology. We present a case of sporadic GGT type II and discuss the clinical features and molecular pathophysiology. Increased awareness of this condition is important as GGT patients may be eligible for ongoing clinical trials of anti-tau therapies.

PRACTICAL NEUROLOGY (2023)

Article Clinical Neurology

Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials

Duncan Street, Edwin Jabbari, Alyssa Costantini, P. Simon Jones, Negin Holland, Timothy Rittman, Marte T. Jensen, Viorica Chelban, Yen Y. Goh, Tong Guo, Amanda J. Heslegrave, Federico Roncaroli, Johannes C. Klein, Olaf Ansorge, Kieren S. J. Allinson, Zane Jaunmuktane, Tamas Revesz, Thomas T. Warner, Andrew J. Lees, Henrik Zetterberg, Lucy L. Russell, Martina Bocchetta, Jonathan D. Rohrer, David J. Burn, Nicola Pavese, Alexander Gerhard, Christopher Kobylecki, P. Nigel Leigh, Alistair Church, Michele T. M. Hu, Henry Houlden, Huw Morris, James B. Rowe

Summary: The study compares candidate clinical trial end points in progressive supranuclear palsy, multiple system atrophy, corticobasal syndrome and related disorders. Neuroimaging metrics generally require smaller sample sizes than cognitive and functional measures, but the optimal outcome measures differ by disease type.
Article Clinical Neurology

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease

Tom Foltynie, Sonia Gandhi, Cristina Gonzalez-Robles, Marie-Louise Zeissler, Georgia Mills, Roger Barker, James Carpenter, Anette Schrag, Anthony Schapira, Oliver Bandmann, Stephen Mullin, Joy Duffen, Kevin McFarthing, Jeremy Chataway, Mahesh Parmar, Camille Carroll

Summary: Multi-arm, multi-stage platform designs have improved the efficiency of clinical trials in the field of oncology. Foltynie et al. discuss the challenges and considerations of using this approach to assess potential disease-modifying treatments in progressive neurological conditions such as Parkinson's disease.
Article Immunology

When should a longer needle be used for intramuscular injection in obese patients? A combined analysis of New Zealand data

Marjan Doppen, Cilein Kearns, Mark Weatherall, Nethmi Kearns, Peter McIntyre, Thomas Hills, Richard Beasley

Summary: This study aimed to determine the thresholds for Body Mass Index (BMI) and arm circumference above which a longer needle is needed for intramuscular (IM) delivery of a vaccine in the deltoid muscle at the recommended site in New Zealand. The analysis of two studies involving 442 adults showed that higher arm circumference and BMI values were associated with the need for a longer needle. Based on the findings, men with an arm circumference of 35 cm and women with an arm circumference of 30 cm should use a longer needle to ensure successful intramuscular injection.

VACCINE (2023)

Review Neurosciences

The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration

Katherine Fodder, Rohan de Silva, Thomas T. Warner, Conceicao Bettencourt

Summary: Neurodegenerative diseases are a group of heterogeneous conditions involving the progressive degeneration of the central or peripheral nervous systems. The underlying mechanisms are not completely understood, but protein aggregation in the brain, such as β-amyloid plaques in Alzheimer's disease and α-synuclein in Parkinson's disease, plays a central role. Dysfunctional oligodendrocytes and myelin loss are increasingly implicated in disease pathogenesis, with aberrant DNA methylation in oligodendrocyte-related genes being recently highlighted. Elucidating the involvement of DNA methylation in neurodegenerative diseases and specific cell types like oligodendrocytes may offer therapeutic opportunities, as DNA methylation is reversible.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Article Clinical Neurology

Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease

Cornelis Blauwendraat, Nahid Tayebi, Elizabeth Geena Woo, Grisel Lopez, Luca Fierro, Marco Toffoli, Naomi Limbachiya, Derralynn Hughes, Vanessa Pitz, Dhairya Patel, Dan Vitale, Mathew J. Koretsky, Dena Hernandez, Raquel Real, Roy N. Alcalay, Mike A. Nalls, Huw R. Morris, Anthony H. V. Schapira, Manisha Balwani, Ellen Sidransky

Summary: This study investigated the contribution of PD risk variants to risk for PD in patients with GD1. The results showed that patients with GD1 who developed PD had a significantly higher PD genetic risk score than those without PD. This suggests that common risk variants may affect underlying biological pathways.

MOVEMENT DISORDERS (2023)

暂无数据